









Mercado
/
Acciones
/
nasdaq-cdna
/

CareDx Inc

CDNA

14.770USD

-0.230-1.53%

Cierre 11/03, 16:00（ET）Cotizaciones retrasadas 15 min

786.06MCap. mercado

15.21P/E TTM



CareDx Inc

14.770

-0.230-1.53%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de CareDx Inc Compañía

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Información de CareDx Inc



Símbolo de cotizaciónCDNA

Nombre de la empresaCareDx Inc

Fecha de salida a bolsaJul 17, 2014

Director ejecutivoMr. John W. Hanna

Número de empleados644

Tipo de seguridadOrdinary Share

Fin del año fiscalJul 17

Dirección8000 Marina Blvd

CiudadBRISBANE

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal94005

Teléfono14152872300

Sitio Webhttps://www.caredx.com/

Símbolo de cotizaciónCDNA

Fecha de salida a bolsaJul 17, 2014

Director ejecutivoMr. John W. Hanna

Ejecutivos de CareDx Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Suresh Gunasekaran

Director

27.45K

Mr. Jeffrey Adam Novack

General Counsel, Secretary

25.20K

-18.08%

Ms. Caroline Corner

Investor Relations

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

Desglose de ingresos

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

81.64M

0.00%

Rest of the world

5.04M

0.00%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

7.64%

The Vanguard Group, Inc.

7.04%

Baron Capital Management, Inc.

4.58%

State Street Investment Management (US)

4.10%

ARK Investment Management LLC

3.95%

Otro

72.70%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

7.64%

The Vanguard Group, Inc.

7.04%

Baron Capital Management, Inc.

4.58%

State Street Investment Management (US)

4.10%

ARK Investment Management LLC

3.95%

Otro

72.70%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

44.54%

Investment Advisor

41.49%

Hedge Fund

10.63%

Individual Investor

3.71%

Research Firm

2.37%

Pension Fund

0.67%

Bank and Trust

0.37%

Insurance Company

0.04%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

443

53.30M

100.13%

-9.09M

2025Q2

458

57.19M

107.22%

-3.81M

2025Q1

463

58.20M

104.56%

-2.86M

2024Q4

457

54.99M

99.23%

-4.48M

2024Q3

452

53.78M

101.72%

-11.43M

2024Q2

424

54.82M

104.96%

-13.18M

2024Q1

450

55.58M

107.13%

-14.92M

2023Q4

462

54.27M

100.29%

-16.52M

2023Q3

493

55.98M

103.34%

-21.97M

2023Q2

517

57.57M

107.02%

-21.82M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

4.07M

7.64%

-142.46K

-3.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.90M

9.21%

+76.50K

+1.59%

Jun 30, 2025

Baron Capital Management, Inc.

2.44M

4.58%

+245.65K

+11.22%

Jun 30, 2025

State Street Investment Management (US)

2.18M

4.1%

-304.45K

-12.25%

Jun 30, 2025

ARK Investment Management LLC

2.10M

3.95%

-247.22K

-10.53%

Jun 30, 2025

Ophir Asset Management Pty Ltd

1.89M

3.56%

+274.63K

+16.97%

Jun 30, 2025

Hood River Capital Management LLC

1.77M

3.32%

+182.03K

+11.49%

Jun 30, 2025

Amova Asset Management Co., Ltd.

1.24M

2.32%

-139.83K

-10.16%

Jun 30, 2025

Gagnon Securities LLC

2.13M

4.01%

+585.21K

+37.78%

Jul 17, 2025

Invesco Advisers, Inc.

1.70M

3.2%

-182.17K

-9.67%

Jun 30, 2025

ETFs relacionados



Actualizado: dom., 2 de nov

Nombre

Proporción

ARK Genomic Revolution ETF

3.04%

ROBO Global Healthcare Technology & Innovation ETF

1.62%

Global X Genomics & Biotechnology ETF

0.87%

Franklin Genomic Advancements ETF

0.58%

SPDR S&P Biotech ETF

0.34%

First Trust Small Cap Growth AlphaDEX Fund

0.27%

Direxion Daily S&P Biotech Bull 3X Shares

0.2%

iShares Micro-Cap ETF

0.17%

First Trust Small Cap Core Alphadex Fund

0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.12%

ARK Genomic Revolution ETF

Proporción3.04%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.62%

Global X Genomics & Biotechnology ETF

Proporción0.87%

Franklin Genomic Advancements ETF

Proporción0.58%

SPDR S&P Biotech ETF

Proporción0.34%

First Trust Small Cap Growth AlphaDEX Fund

Proporción0.27%

Direxion Daily S&P Biotech Bull 3X Shares

Proporción0.2%

iShares Micro-Cap ETF

Proporción0.17%

First Trust Small Cap Core Alphadex Fund

Proporción0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporción0.12%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

